Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000526014 | SCV000651154 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001558061 | SCV001779934 | likely benign | not provided | 2021-04-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377138 | SCV002674921 | likely benign | Cardiovascular phenotype | 2019-04-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002497178 | SCV002808860 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26 | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001558061 | SCV003917568 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7, BS1 |
Prevention |
RCV003945287 | SCV004765918 | likely benign | FLNC-related disorder | 2019-11-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |